These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35586947)

  • 1. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
    Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF/ICSI.
    Mostinckx L; Goyens E; Mackens S; Roelens C; Boudry L; Uvin V; Segers I; Schoemans C; Drakopoulos P; Blockeel C; De Vos M
    Hum Reprod; 2024 Mar; 39(3):586-594. PubMed ID: 38177084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation.
    Piechota S; Marchante M; Giovannini A; Paulsen B; Potts KS; Rockwell G; Aschenberger C; Noblett AD; Figueroa AB; Sanchez M; Barrachina F; Wiemer K; Guzman L; Belchin P; Pierson Smela M; Fortuna PRJ; Chatterjee P; Tran ND; Kelk DA; Forti M; Marcinyshyn S; Smith T; McCulloh DH; Fernandez-Gonzalez MJ; Abittan B; Ortiz S; Klein JU; Klatsky P; Ordonez-Perez D; Kramme CC
    Hum Reprod; 2023 Dec; 38(12):2456-2469. PubMed ID: 37815487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures.
    Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J
    Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients.
    Karavani G; Vedder K; Gutman-Ido E; Gruda Sussman R; Goldschmidt N; Mordechai-Daniel T; Ben-Meir A; Imbar T
    Hum Reprod; 2023 Sep; 38(9):1705-1713. PubMed ID: 37414543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
    Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
    Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF2, LIF, and IGF1 (FLI) supplementation during human in vitro maturation enhances markers of gamete competence.
    Amargant F; Zhou LT; Yuan Y; Nahar A; Krisher RL; Spate LD; Roberts RM; Prather RS; Rowell EE; Laronda MM; Duncan FE
    Hum Reprod; 2023 Oct; 38(10):1938-1951. PubMed ID: 37608600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
    Gayete-Lafuente S; Turan V; Oktay KH
    J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count.
    Guzman L; Ortega-Hrepich C; Polyzos NP; Anckaert E; Verheyen G; Coucke W; Devroey P; Tournaye H; Smitz J; De Vos M
    Hum Reprod; 2013 May; 28(5):1261-6. PubMed ID: 23427238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
    Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
    Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
    Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
    Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of breast cancer prognostic factors on ovarian reserve and response in fertility preservation.
    Grynberg M; Zeghari F; Peigné M; Benoit A; Rakrouki S; Sifer C; Mayeur A; Saïs E; Sonigo C
    Reprod Biomed Online; 2024 Nov; 49(5):104109. PubMed ID: 39182453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-free 3D culture supports human follicular development from the unilaminar to the antral stage in vitro yielding morphologically normal metaphase II oocytes.
    Xu F; Lawson MS; Bean Y; Ting AY; Pejovic T; De Geest K; Moffitt M; Mitalipov SM; Xu J
    Hum Reprod; 2021 Apr; 36(5):1326-1338. PubMed ID: 33681988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.